v3.26.1
Condensed Consolidated Statement of Cash Flows (Unaudited) - USD ($)
 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Cash flows from operating activities:    
Net loss $ (23,238,998) $ (13,404,771)
Adjustments to reconcile net loss to net cash used in operating activities:    
Acquired in-process research and development charge 6,500,000 0
Share-based compensation expense 937,322 682,831
Depreciation and amortization expense 11,334 8,120
Reduction in the carrying amount of operating lease right-of-use asset 70,244 52,737
Changes in operating assets and liabilities:    
Prepaid expenses and other current assets (470,017) 34,972
Accounts payable 755,322 958,960
Accrued expenses and other current liabilities (2,946,188) 855,651
Operating lease liability (68,130) (52,061)
Net cash used in operating activities (18,449,111) (10,863,561)
Cash flows from investing activities:    
Acquired in-process research and development (4,500,000) 0
Purchase of property and equipment (55,746) (33,948)
Net cash used in investing activities (4,555,746) (33,948)
Cash flows from financing activities:    
Payment of offering costs from the sale of common stock from ATM facility 0 (15,268)
Net cash used in financing activities 0 (15,268)
Net decrease in cash and cash equivalents (23,004,857) (10,912,777)
Cash and cash equivalents at beginning of period 65,995,228 94,429,824
Cash and cash equivalents at end of period 42,990,371 83,517,047
Supplemental disclosure of non-cash activities:    
Right-of-use asset obtained in exchange for lease obligation 201,058 0
Acquired in-process research and development charge included in accrued expenses $ 2,000,000 $ 0